Osiris Therapeutics, Inc. actively conducts clinical trials as part of its commitment to developing innovative regenerative medicine therapies. Clinical trials are essential for evaluating the safety and effectiveness of new treatments before they can be approved for widespread use. Osiris focuses on advancing its product pipeline, which may include therapies for various conditions, primarily in the field of regenerative medicine. The process typically involves multiple phases, each designed to gather specific data regarding the intervention's impact on participants. To find more detailed information about ongoing or completed trials, including their results and specific areas of research, individuals may refer to the clinical trial section on Osiris Therapeutics, Inc.’s current web page. There, one can also find information on eligibility criteria and how to get involved in trials if that is of interest.